The Directors have stated they will be converting their options...

The Directors have stated they will be converting their options so it does not matter what announcements are put out - I would expect them to do that anyway or their credibility is well and truly shot. Traders will stuff around with the price for a crumb or two - that's their prerogative.

Unlike some on this forum who seem to be obsessed with the adrenaline fix of "today", there are many who read these forums who are here for the longer term targets. The Company has the tech, the FDA approval to the original tech, the pharmaceutical partnerships and a growing footprint through partnerships and investments in an age when health care, telehealth and personal healthcare are front and centre of many peoples minds.

Like any spec, these guys have had a few missteps. But FFS, anyone here is invested in the spec end of the market, so accept and admit to those risks or pick up your bat and go home. No one forcing anyone to invest in this.

Yes there are risks in China, take them into account in making an investment. Don't like it, don't invest